LT3244889T - Farmacinė kompozicija, skirta mikozės gydymui - Google Patents

Farmacinė kompozicija, skirta mikozės gydymui

Info

Publication number
LT3244889T
LT3244889T LTEP16700189.0T LT16700189T LT3244889T LT 3244889 T LT3244889 T LT 3244889T LT 16700189 T LT16700189 T LT 16700189T LT 3244889 T LT3244889 T LT 3244889T
Authority
LT
Lithuania
Prior art keywords
mycose
treatment
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
LTEP16700189.0T
Other languages
English (en)
Inventor
Claudio Milanese
Alessandra CAPEZZONE DE JOANNON
Serena Tongiani
Luca Donati
Original Assignee
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. filed Critical Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Publication of LT3244889T publication Critical patent/LT3244889T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
LTEP16700189.0T 2015-01-13 2016-01-08 Farmacinė kompozicija, skirta mikozės gydymui LT3244889T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15150904 2015-01-13
PCT/EP2016/050272 WO2016113194A1 (en) 2015-01-13 2016-01-08 Pharmaceutical composition for the treatment of mycosis

Publications (1)

Publication Number Publication Date
LT3244889T true LT3244889T (lt) 2020-08-10

Family

ID=52396443

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP16700189.0T LT3244889T (lt) 2015-01-13 2016-01-08 Farmacinė kompozicija, skirta mikozės gydymui

Country Status (29)

Country Link
US (1) US9962372B2 (lt)
EP (1) EP3244889B1 (lt)
JP (1) JP6714597B2 (lt)
KR (1) KR102606081B1 (lt)
CN (1) CN107106690B (lt)
AR (1) AR103381A1 (lt)
AU (1) AU2016208200B2 (lt)
BR (1) BR112017014295B1 (lt)
CA (1) CA2970060C (lt)
CY (1) CY1122979T1 (lt)
DK (1) DK3244889T3 (lt)
EA (1) EA035748B1 (lt)
ES (1) ES2794824T3 (lt)
GE (2) GEP20196962B (lt)
HR (1) HRP20200815T1 (lt)
HU (1) HUE049877T2 (lt)
IL (1) IL252774A0 (lt)
LT (1) LT3244889T (lt)
MD (1) MD3244889T2 (lt)
ME (1) ME03736B (lt)
MX (1) MX378376B (lt)
PL (1) PL3244889T3 (lt)
PT (1) PT3244889T (lt)
RS (1) RS60508B1 (lt)
SG (1) SG11201704964RA (lt)
SI (1) SI3244889T1 (lt)
SM (1) SMT202000277T1 (lt)
UA (1) UA120864C2 (lt)
WO (1) WO2016113194A1 (lt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018007288A1 (en) * 2016-07-08 2018-01-11 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Pharmaceutical composition comprising benzydamine
CN112514904B (zh) * 2021-01-26 2021-10-26 青岛农业大学 盐酸苄达明在制备用于防治由植物病原菌引起的植物病害的杀菌剂中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0665076A (ja) * 1992-08-19 1994-03-08 Pola Chem Ind Inc 抗真菌外用剤
GB9224598D0 (en) 1992-11-24 1993-01-13 Smithkline Beecham Plc Novel compositions
IT1274655B (it) * 1995-02-28 1997-07-18 Smithkline Beecham Farma Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico
US6913759B2 (en) * 2003-03-11 2005-07-05 Curatek Pharmaceuticals Holding, Inc. Gel composition and method for treatment of vaginal infections
DK2018164T3 (en) * 2006-05-12 2017-06-12 Christian Noe Use of combination preparations comprising antimycotics
CN1887352A (zh) * 2006-07-13 2007-01-03 徐艳 治疗眼部真菌和细菌感染的组合物
GB201000196D0 (en) * 2010-01-07 2010-02-24 Galvez Julian M Novel combination

Also Published As

Publication number Publication date
ME03736B (me) 2021-01-20
GEAP201814557A (en) 2018-11-12
SG11201704964RA (en) 2017-07-28
JP6714597B2 (ja) 2020-06-24
HRP20200815T1 (hr) 2020-08-07
MD3244889T2 (ro) 2020-06-30
CY1122979T1 (el) 2021-10-29
AU2016208200A1 (en) 2017-06-29
HUE049877T2 (hu) 2020-10-28
ES2794824T3 (es) 2020-11-19
RS60508B1 (sr) 2020-08-31
CA2970060C (en) 2023-10-03
EA035748B1 (ru) 2020-08-05
SI3244889T1 (sl) 2020-08-31
AU2016208200B2 (en) 2020-09-03
UA120864C2 (uk) 2020-02-25
CN107106690B (zh) 2020-11-10
PT3244889T (pt) 2020-06-04
CA2970060A1 (en) 2016-07-21
KR20170101941A (ko) 2017-09-06
BR112017014295A2 (pt) 2018-03-06
WO2016113194A1 (en) 2016-07-21
JP2018501277A (ja) 2018-01-18
AR103381A1 (es) 2017-05-03
US9962372B2 (en) 2018-05-08
EP3244889B1 (en) 2020-03-04
PL3244889T3 (pl) 2020-11-02
US20180000783A1 (en) 2018-01-04
MX2017008879A (es) 2018-03-28
EP3244889A1 (en) 2017-11-22
HK1246146A1 (zh) 2018-09-07
GEP20196962B (en) 2019-04-10
EA201791483A1 (ru) 2017-11-30
MX378376B (es) 2025-03-10
CN107106690A (zh) 2017-08-29
DK3244889T3 (da) 2020-06-02
IL252774A0 (en) 2017-08-31
BR112017014295B1 (pt) 2023-04-25
SMT202000277T1 (it) 2020-09-10
KR102606081B1 (ko) 2023-11-24

Similar Documents

Publication Publication Date Title
IL285114A (en) Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
MA41265A (fr) Compositions pour administration de médicaments iléo-jéjunal.
DK3256138T3 (da) Farmaceutiske sammensætninger omfattende meloxicam
DK3328880T3 (da) Terapeutiske midler
EP3513809A4 (en) MEDICAL COMPOSITION
SI3529248T1 (sl) Farmacevtske spojine
LT3594238T (lt) Antikūno kompozicijos, skirtos navikų gydymui
LT3139925T (lt) Valbenazino dozavimo režimas, skirtas gydyti hiperkinetinio judėjimo sutrikimus
LT3468965T (lt) 1-tetrahidropiranilkarbonil-2,3-dihidro-1h-indolo junginiai vėžio gydymui
DK3253382T3 (da) Farmaceutiske sammensætninger til kombinationsterapi
HUE059694T2 (hu) Készítmény rák kezelésére
LT3390390T (lt) Bipirazolilo dariniai, tinkami naudoti autoimuninių ligų gydymui
BR112016018062A2 (pt) compostos terapêuticos, composição farmacêutica e usos
DK3529240T3 (da) Farmaceutiske forbindelser
LT3389633T (lt) Farmacinės kompozicijos, apimančios fenilaminopirimidino darinį
LT3273957T (lt) Biotinas, skirtas demielinizuojančių neuropatijų gydymui
DK3157506T3 (da) Smagsmaskeret oral, farmaceutisk sammensætning
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning
EP3334447A4 (en) CCK2R-drug conjugates
DK3506956T3 (da) Lægemiddel, særlig til behandling af fistler
LT3500572T (lt) Citizino dariniai, skirti priklausomybių gydymui
DK3389638T3 (da) Farmaceutisk sammensætning omfattende pimobendan
EP3395344A4 (en) MEDICINE
DK3288967T3 (da) Farmaceutisk forbindelse
DK3089740T3 (da) Farmaceutisk sammensætning